# A Phase I Dose-escalation Trial of Definitive Single Dose Stereotactic Body Radiotherapy in Low-risk Breast Cancer Patients: DESERT I Trial

> **NCT06671691** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Universitat de les Illes Balears** · enrollment: 15 (estimated)

## Conditions studied

- Breast Cancer Early Stage Breast Cancer (Stage 1-3)
- SBRT

## Interventions

- **RADIATION:** SBRT level I
- **RADIATION:** SBRT level II
- **RADIATION:** SBRT level III
- **RADIATION:** SBRT level IV
- **RADIATION:** SBRT level V

## Key facts

- **NCT ID:** NCT06671691
- **Lead sponsor:** Universitat de les Illes Balears
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-27
- **Primary completion:** 2025-09
- **Final completion:** 2027-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671691, "A Phase I Dose-escalation Trial of Definitive Single Dose Stereotactic Body Radiotherapy in Low-risk Breast Cancer Patients: DESERT I Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06671691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*